Hikma Pharmaceuticals Overview

  • Founded
  • 1978

Founded
  • Status
  • Public

  • Employees
  • 8,700

Employees
  • Stock Symbol
  • HIK

Stock Symbol
  • Investments
  • 21

  • Share Price
  • $19.35

  • (As of Monday Closing)

Hikma Pharmaceuticals General Information

Description

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Contact Information

Website
www.hikma.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
  • 1 New Burlington Place
  • London W1S 2HR
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hikma Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.35 $19.51 $0.40 - $36.32 $4.26B 220M 883K $1.51

Hikma Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 4,728,277 7,531,560 8,410,786 6,688,814
Revenue 2,550,000 2,553,000 2,341,000 2,207,000
EBITDA 699,000 766,000 742,000 653,000
Net Income 346,000 421,000 431,000 486,000
Total Assets 4,747,000 4,372,000 4,135,000 3,930,000
Total Debt 1,551,000 846,000 932,000 685,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hikma Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hikma Pharmaceuticals‘s full profile, request access.

Request a free trial

Hikma Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded
Pharmaceuticals
London, United Kingdom
8,700 As of 2022
00000
000000000 00000

000 00

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
000000000000000
Ramapo, NY
0000 As of 0000
000.00
0.000 0000-00-00
000000&0 000.00

000 00

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
000000000000000
Mumbai, India
00000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hikma Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Par Pharmaceutical Companies Formerly PE-Backed Ramapo, NY 0000 000.00 000000&0 000.00
000 00000000000000 Corporation Mumbai, India 00000 000000000000
000000 Corporation Carros, France 0000 00000000
00000000 Corporation Basel, Switzerland 000000 000000000000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
You’re viewing 5 of 5 competitors. Get the full list »

Hikma Pharmaceuticals Patents

Hikma Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100125051-A1 Parenteral formulations comprising sugar-based esters and ethers Granted 19-Nov-2008 000000000 00
US-8541360-B2 Parenteral formulations comprising sugar-based esters and ethers Active 19-Nov-2008 000000000 00

Hikma Pharmaceuticals Executive Team (28)

Name Title Board Seat Contact Info
Riad Mechlaoui President of Injectables
Khalid Nabilsi Chief Financial Officer
Bassam Kanaan Executive Vice President, Corporate Development & Mergers & Acquisitions
Laith Rahim Global data management specialist
Henry Knowles General Counsel, Legal
You’re viewing 5 of 28 executive team members. Get the full list »

Hikma Pharmaceuticals Board Members (13)

Name Representing Role Since
0000000 0000000 Hikma Pharmaceuticals Board Member 000 0000
000000 0000 Self Board Member 000 0000
0000 0000000000 Hikma Pharmaceuticals Board Member 000 0000
00000 00000000 Hikma Pharmaceuticals Executive Vice Chairman and President of MENA 000 0000
00000000 000 00-00000 Self Non-Executive Director 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Hikma Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hikma Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hikma Pharmaceuticals‘s full profile, request access.

Request a free trial

Hikma Pharmaceuticals Investments & Acquisitions (21)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 21-Apr-2022 0000000000 00000 Pharmaceuticals 00000000
00000000 0000 03-Feb-2022 0000000000 000.00 Pharmaceuticals 0000 0000
000000 000000 02-Jan-2019 0000000000 0000.00 Medical Supplies 0000 0000
000000 000000 29-Feb-2016 0000000000 00.000 Pharmaceuticals 0000 0000
EIMC United Pharmaceuticals 08-Sep-2015 Merger/Acquisition 0000 Drug Discovery
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Hikma Pharmaceuticals Subsidiaries (5)

Company Name Industry Location Founded
Hikma Ventures Corporate Venture Capital London, United Kingdom 2015
0000000000 Pharmaceuticals Carlsbad, CA 0000
00000000000 Distributors (Healthcare) Grafelfing, Germany 0000
0000 0000000000000 Pharmaceuticals Al Salt, Jordan 0000
0000000000 Pharmaceuticals Casablanca, Morocco 0000
To view Hikma Pharmaceuticals’s complete subsidiaries history, request access »

Hikma Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000000000 00 17-Sep-2014 000000000 00000 00 Completed
  • 00000 000000000000
000 00000 00000000 15-Jul-2014 000000000000000000 00000 Completed
  • 00000 000000000000
Unimark Remedies 15-Apr-2011 Corporate 000.00 Completed
To view Hikma Pharmaceuticals’s complete exits history, request access »